{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T23:48:03Z","timestamp":1778888883140,"version":"3.51.4"},"reference-count":40,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Heart Failure"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.jchf.2024.07.007","type":"journal-article","created":{"date-parts":[[2024,9,4]],"date-time":"2024-09-04T14:44:22Z","timestamp":1725461062000},"page":"1994-2006","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Functional Status and Quality of Life in Light-Chain Amyloidosis"],"prefix":"10.1016","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7725-9318","authenticated-orcid":false,"given":"Olivier F.","family":"Clerc","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shilpa","family":"Vijayakumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah A.M.","family":"Cuddy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3673-0104","authenticated-orcid":false,"given":"Giada","family":"Bianchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jocelyn","family":"Canseco Neri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandra","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominik C.","family":"Benz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yesh","family":"Datar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie Foley","family":"Kijewski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew J.","family":"Yee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6424-4413","authenticated-orcid":false,"given":"Frederick L.","family":"Ruberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronglih","family":"Liao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rodney H.","family":"Falk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vaishali","family":"Sanchorawala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1462-1185","authenticated-orcid":false,"given":"Sharmila","family":"Dorbala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jchf.2024.07.007_bib1","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/j.jacc.2016.06.053","article-title":"AL (light-chain) cardiac amyloidosis: a review of diagnosis and therapy","volume":"68","author":"Falk","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2024.07.007_bib2","doi-asserted-by":"crossref","first-page":"3751","DOI":"10.1200\/JCO.2004.03.029","article-title":"Serum cardiac troponins and N-terminal pro-brain natriuretic peptide: a staging system for primary systemic amyloidosis","volume":"22","author":"Dispenzieri","year":"2004","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jchf.2024.07.007_bib3","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13023-016-0564-2","article-title":"The burden of amyloid light chain amyloidosis on health-related quality of life","volume":"12","author":"Bayliss","year":"2017","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.jchf.2024.07.007_bib4","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1002\/1097-0142(19800415)45:8<2220::AID-CNCR2820450835>3.0.CO;2-Q","article-title":"Evaluation of patients with advanced cancer using the Karnofsky performance status","volume":"45","author":"Yates","year":"1980","journal-title":"Cancer"},{"key":"10.1016\/j.jchf.2024.07.007_bib5","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.cardfail.2021.04.013","article-title":"Physical functioning in heart failure with preserved ejection fraction","volume":"27","author":"Cosiano","year":"2021","journal-title":"J\u00a0Card Fail"},{"key":"10.1016\/j.jchf.2024.07.007_bib6","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1067\/mhl.2002.124554","article-title":"Validity and reliability of the NYHA classes for\u00a0measuring research outcomes in patients with cardiac disease","volume":"31","author":"Bennett","year":"2002","journal-title":"Heart Lung"},{"key":"10.1016\/j.jchf.2024.07.007_bib7","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1007\/s11897-017-0330-3","article-title":"Six-minute walk test for assessing physical functional capacity in chronic heart failure","volume":"14","author":"Du","year":"2017","journal-title":"Curr Heart Fail Rep"},{"key":"10.1016\/j.jchf.2024.07.007_bib8","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s11136-008-9416-4","article-title":"Disease-specific health-related quality of life questionnaires for heart failure: a systematic review with meta-analyses","volume":"18","author":"Garin","year":"2009","journal-title":"Qual Life Res"},{"key":"10.1016\/j.jchf.2024.07.007_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.cpcardiol.2023.101592","article-title":"Association between disease-specific health-related quality of life and all-cause mortality in patients with heart failure: a meta-analysis","volume":"48","author":"Xu","year":"2023","journal-title":"Curr Probl Cardiol"},{"key":"10.1016\/j.jchf.2024.07.007_bib10","series-title":"Guidance for industry","article-title":"Patient-reported outcome measures: use in medical product development to support labeling claims","year":"2009"},{"issue":"6","key":"10.1016\/j.jchf.2024.07.007_bib11","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.121.009038","article-title":"Proposed cardiac end points for clinical trials in immunoglobulin light chain amyloidosis: report from the Amyloidosis Forum Cardiac Working Group","volume":"15","author":"Maurer","year":"2022","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jchf.2024.07.007_bib12","doi-asserted-by":"crossref","first-page":"153","DOI":"10.2147\/PROM.S399658","article-title":"Health-related quality of life instruments for clinical trials in al amyloidosis: report from the Amyloidosis Forum HRQOL Working Group","volume":"14","author":"Rizio","year":"2023","journal-title":"Patient Relat Outcome Meas"},{"key":"10.1016\/j.jchf.2024.07.007_bib13","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/bjh.14586","article-title":"The six-minute walk test in patients with AL amyloidosis: a single centre case series","volume":"177","author":"Pulido","year":"2017","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jchf.2024.07.007_bib14","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1007\/s12350-019-01760-6","article-title":"ASNC\/AHA\/ASE\/EANM\/HFSA\/ISA\/SCMR\/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: part 1 of 2-evidence base and standardized methods of imaging","volume":"26","author":"Dorbala","year":"2019","journal-title":"J\u00a0Nucl Cardiol"},{"key":"10.1016\/j.jchf.2024.07.007_bib15","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/bjh.14585","article-title":"The six-minute walk test is a valuable measure of functional change following chemotherapy for AL (light-chain) cardiac amyloidosis","volume":"177","author":"Decker","year":"2017","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jchf.2024.07.007_bib16","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1080\/13506129.2017.1293516","article-title":"Six-minute walk test (6MWT) in AL amyloidosis\u2014baseline and 12-month follow-up after chemotherapy","volume":"24","author":"Flatman","year":"2017","journal-title":"Amyloid"},{"key":"10.1016\/j.jchf.2024.07.007_bib17","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1136\/heartjnl-2021-320703","article-title":"Prognostic importance of the 6\u00a0min walk test in light chain (AL) amyloidosis","volume":"108","author":"Cohen","year":"2022","journal-title":"Heart"},{"issue":"2","key":"10.1016\/j.jchf.2024.07.007_bib18","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2023-002310","article-title":"Prognosis of light chain amyloidosis: a multivariable analysis for survival prediction in patients with cardiac involvement proven by endomyocardial biopsy","volume":"10","author":"Aurich","year":"2023","journal-title":"Open Heart"},{"key":"10.1016\/j.jchf.2024.07.007_bib19","doi-asserted-by":"crossref","first-page":"6080","DOI":"10.1182\/bloodadvances.2023010324","article-title":"Predictors of treatment response and survival outcomes in patients with advanced cardiac AL amyloidosis","volume":"7","author":"Gustine","year":"2023","journal-title":"Blood Adv"},{"key":"10.1016\/j.jchf.2024.07.007_bib20","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1016\/j.jcmg.2020.02.025","article-title":"Improved quantification of cardiac amyloid burden in systemic light chain amyloidosis: redefining early disease?","volume":"13","author":"Cuddy","year":"2020","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.jchf.2024.07.007_bib21","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.jcmg.2021.09.032","article-title":"Myocardial composition in light-chain cardiac amyloidosis more than 1 year after successful therapy","volume":"15","author":"Cuddy","year":"2022","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.jchf.2024.07.007_bib22","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s12350-019-01761-5","article-title":"ASNC\/AHA\/ASE\/EANM\/HFSA\/ISA\/SCMR\/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: part 2 of 2-diagnostic criteria and appropriate utilization","volume":"27","author":"Dorbala","year":"2020","journal-title":"J\u00a0Nucl Cardiol"},{"key":"10.1016\/j.jchf.2024.07.007_bib23","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1007\/s00259-014-2787-6","article-title":"Imaging cardiac amyloidosis: a pilot study using 1\u2078F-florbetapir positron emission tomography","volume":"41","author":"Dorbala","year":"2014","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.jchf.2024.07.007_bib24","doi-asserted-by":"crossref","first-page":"e296","DOI":"10.1371\/journal.pmed.0040296","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"4","author":"von Elm","year":"2007","journal-title":"PLoS Med"},{"issue":"11","key":"10.1016\/j.jchf.2024.07.007_bib25","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/j.jcmg.2024.05.004","article-title":"Myocardial characteristics, cardiac structure, and\u00a0cardiac function in systemic light-chain amyloidosis","volume":"17","author":"Clerc","year":"2024","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.jchf.2024.07.007_bib26","doi-asserted-by":"crossref","first-page":"4722","DOI":"10.1093\/eurheartj\/ehac363","article-title":"Cardiovascular magnetic resonance in light-chain amyloidosis to guide treatment","volume":"43","author":"Martinez-Naharro","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jchf.2024.07.007_bib27","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1093\/eurheartj\/ehab507","article-title":"Longitudinal strain is an independent predictor of survival and response to therapy in patients with systemic AL amyloidosis","volume":"43","author":"Cohen","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jchf.2024.07.007_bib28","doi-asserted-by":"crossref","first-page":"4188","DOI":"10.1073\/pnas.0912263107","article-title":"Amyloidogenic light chains induce cardiomyocyte contractile dysfunction and apoptosis via a non-canonical p38alpha MAPK pathway","volume":"107","author":"Shi","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jchf.2024.07.007_bib29","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-15424-3","article-title":"Proteotoxicity in cardiac amyloidosis: amyloidogenic light chains affect the levels of intracellular proteins in human heart cells","volume":"7","author":"Imperlini","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.jchf.2024.07.007_bib30","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1080\/13506129.2017.1295944","article-title":"A\u00a0good clonal response to chemotherapy in AL amyloidosis is associated with improved quality of life and function at 1 year","volume":"24","author":"Carter","year":"2017","journal-title":"Amyloid"},{"key":"10.1016\/j.jchf.2024.07.007_bib31","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/s41408-021-00412-8","article-title":"Changes in patient-reported outcomes in light chain amyloidosis in the first year after diagnosis and relationship to NT-proBNP change","volume":"11","author":"D'Souza","year":"2021","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.jchf.2024.07.007_bib32","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1111\/bjh.18645","article-title":"Linking changes in quality of life to haematologic response and survival in systemic immunoglobulin light-chain amyloidosis","volume":"201","author":"Cohen","year":"2023","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jchf.2024.07.007_bib33","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1182\/blood-2004-01-0089","article-title":"Improvement in quality of life of patients with AL amyloidosis treated with high-dose melphalan and autologous stem cell transplantation","volume":"104","author":"Seldin","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.jchf.2024.07.007_bib34","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/bjh.14889","article-title":"A\u00a0longitudinal evaluation of health-related quality of life in patients with AL amyloidosis: associations with health outcomes over time","volume":"179","author":"Sanchorawala","year":"2017","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jchf.2024.07.007_bib35","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1002\/ajh.26536","article-title":"Health-related quality of life in patients with light chain amyloidosis treated with bortezomib, cyclophosphamide, and dexamethasone\u00a0+\/- daratumumab: results from the ANDROMEDA study","volume":"97","author":"Sanchorawala","year":"2022","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jchf.2024.07.007_bib36","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1002\/ajh.26866","article-title":"Quality of life and symptoms among patients with relapsed\/refractory AL amyloidosis treated with ixazomib-dexamethasone versus physician's choice","volume":"98","author":"Sanchorawala","year":"2023","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jchf.2024.07.007_bib37","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1093\/eurheartj\/ehu444","article-title":"T1 mapping and survival in systemic light-chain amyloidosis","volume":"36","author":"Banypersad","year":"2015","journal-title":"Eur Heart J"},{"issue":"8","key":"10.1016\/j.jchf.2024.07.007_bib38","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.jcmg.2024.05.002","article-title":"Prognostic value of left ventricular 18F-florbetapir uptake in systemic light-chain amyloidosis","volume":"17","author":"Clerc","year":"2024","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.jchf.2024.07.007_bib39","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1002\/ajh.24676","article-title":"Hematology patient reported symptom screen to assess quality of life for AL amyloidosis","volume":"92","author":"Warsame","year":"2017","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jchf.2024.07.007_bib40","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s41669-019-0122-7","article-title":"Associations between health-related quality of life and self-reported emergency room department visits and inpatient\u00a0hospitalizations: insights from a secondary data analysis of patients with light-chain (AL)\u00a0amyloidosis","volume":"3","author":"McCausland","year":"2019","journal-title":"Pharmacoecon Open"}],"container-title":["JACC: Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213177924005626?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213177924005626?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T01:10:53Z","timestamp":1764551453000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213177924005626"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":40,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S2213177924005626"],"URL":"https:\/\/doi.org\/10.1016\/j.jchf.2024.07.007","relation":{},"ISSN":["2213-1779"],"issn-type":[{"value":"2213-1779","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Functional Status and Quality of Life in Light-Chain Amyloidosis","name":"articletitle","label":"Article Title"},{"value":"JACC: Heart Failure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jchf.2024.07.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}